| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 03/18/2004 | US20040053966 Chemical derivatives and their application as antitelomerase agent |
| 03/18/2004 | US20040053965 N-type calcium channel antagonists for the treatment of pain |
| 03/18/2004 | US20040053964 N-type calcium channel antagonists for the treatment of pain |
| 03/18/2004 | US20040053963 Urotensin-II receptor antagonists |
| 03/18/2004 | US20040053932 Peptide deformylase inhibtors |
| 03/18/2004 | US20040053908 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 03/18/2004 | US20040053890 Naphthalene derivatives |
| 03/18/2004 | US20040053842 Cholesterol ester transfer protein inhibitors for use in treating atherosclerosis optionally in combination with other antihypertensive agents |
| 03/18/2004 | CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | CA2495939A1 Cathepsin cysteine protease inhibitors |
| 03/17/2004 | EP1397505A2 Characterising polypeptides |
| 03/17/2004 | EP1397136A1 Heterocyclic beta-aminoacids and their use as anti-epileptogenic agents |
| 03/17/2004 | EP1144543B1 Electroluminescent quinolates |
| 03/17/2004 | EP1144365B1 Inhibitors of alpha-4 beta-1 mediated cell adhesion |
| 03/17/2004 | CN1483031A Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them |
| 03/17/2004 | CN1483013A 润滑油组合物 The lubricating oil composition |
| 03/16/2004 | US6706881 Methods for preparing CETP inhibitors |
| 03/16/2004 | US6706765 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 03/16/2004 | US6706751 Dihydroindole and tetrahydroquinoline derivatives |
| 03/16/2004 | US6706733 The beta crystal form and/or gamma crystal form |
| 03/16/2004 | US6706732 Nasal preparation of guanidinoimino quinoline derivatives |
| 03/11/2004 | WO2004005279A3 Substituted anthranilic amide derivatives and methods of use |
| 03/11/2004 | WO2003053945A3 Urea derivatives and their use as vanilloid receptor antagonists |
| 03/11/2004 | US20040049038 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease |
| 03/11/2004 | US20040049031 Method for the synthesis of quinoline derivatives |
| 03/11/2004 | US20040048867 Especially quinoline carbonyl pyrrolidines with binding selectivity to benzodiazepine site of GABAA receptor to treatanxiety, depression, a sleep disorder, or cognitive impairment. |
| 03/11/2004 | DE10236910A1 Substituierte 1,2,3,4-Tetrahydrochinolinderivate Substituted 1,2,3,4-tetrahydroquinoline |
| 03/10/2004 | EP1396490A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives |
| 03/10/2004 | EP1395571A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 03/10/2004 | EP1395564A1 Quinoline derivatives as ligands for the neuropeptide y receptor |
| 03/10/2004 | EP1395563A1 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods |
| 03/10/2004 | EP1395548A1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments |
| 03/10/2004 | CN1481377A Cyclic Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF alhpa |
| 03/10/2004 | CN1481366A Dihydroindole and tetrahydroquinoline derivatives |
| 03/10/2004 | CN1481365A Cyclization process step in making of quinolones and naphthyridines |
| 03/10/2004 | CN1141298C Carbostyril derivs. for inhibiting skin erythema and/or skin pigmentation |
| 03/09/2004 | US6703384 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 03/04/2004 | WO2004018436A2 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 03/04/2004 | WO2004018430A1 COMPOUND HAVING TGFß INHIBITORY ACTIVITY AND MEDICINAL COMPOSITION CONTAINING THE SAME |
| 03/04/2004 | WO2004018429A2 Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 03/04/2004 | WO2004018414A2 Antibacterial agents |
| 03/04/2004 | WO2004017917A2 Method for the prevention and/or treatment of atherosclerosis |
| 03/04/2004 | WO2003082350A3 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 03/04/2004 | WO2003045878A3 2,w-diaminocarboxylic acid compounds |
| 03/04/2004 | WO2002098856A3 Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists |
| 03/04/2004 | WO2002072654A3 Polymers and oligomers, their synthesis, and electronic devices incorporating same |
| 03/04/2004 | US20040044217 Process to produce halo-4-phenoxyquinolines |
| 03/04/2004 | US20040044081 Hypotensive agents; cardiovascular disorders; anticholesterol agents; antiarrhythmia agents |
| 03/04/2004 | US20040044075 Alpha acyloxyacetamides for kallikrein and urokinase inhibition |
| 03/04/2004 | US20040044047 Alpha and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 03/04/2004 | US20040043984 3,4-Dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors |
| 03/04/2004 | US20040043983 Cardiovascular disorders; antiarthritic agents; inflammatory bowel disorders; vision defects; respiratory system disorders |
| 03/04/2004 | CA2496175A1 Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 03/04/2004 | CA2495682A1 Method for the prevention and/or treatment of atherosclerosis |
| 03/03/2004 | EP1392683A1 SUBSTITUTED 4 i H /i -CHROMENES AND ANALOGS AS ACTIVATORS OFGASP ASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF |
| 03/03/2004 | EP1392677A2 Chiral broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions |
| 03/03/2004 | EP1392655A2 Potassium channel openers |
| 03/03/2004 | EP1392644A1 Cinnamide derivatives as kcnq potassium channel modulators |
| 03/03/2004 | EP1392637A2 Modulators of peroxisome proliferator activated receptors |
| 03/03/2004 | EP1392315A1 Methods of treating alzheimer's disease |
| 03/03/2004 | EP1392283A1 Substituted coumarins and quinolines as caspases activators |
| 03/03/2004 | EP1392280A2 Arylsulfonamide ethers, and methods of use thereof |
| 03/03/2004 | EP1017692B1 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 03/03/2004 | EP0929217B1 Sordarin derivatives |
| 03/03/2004 | CN1479724A Pyridione derivatives for tretment of atherosclerosis |
| 03/03/2004 | CN1140516C Quinoline and quinoxaline compounds which inhibits platelet-derived growth factor on/or p56lck tyrosine kinases |
| 03/03/2004 | CA2438909A1 1,4-substituted cyclohexane derivatives |
| 03/03/2004 | CA2400996A1 1,4-substituted cyclohexane derivatives |
| 03/02/2004 | US6699992 Reacting m-fluoroacetophenone compound with alkyl carbonate; reacting ester obtained with alkyl orthoformate and amine; cyclization in base |
| 03/02/2004 | US6699989 Antiviral and antimicrobial guanidine or biguanidine derivatives |
| 03/02/2004 | US6699891 Npyy5 antagonists |
| 03/02/2004 | US6699890 Phosphodiesterase 4 inhibitors |
| 03/02/2004 | US6699879 Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists |
| 03/02/2004 | US6699877 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 02/26/2004 | WO2004016596A1 Condensed heterocyclic compounds as pde-iv inhibitors for the treatment of inflammatory and allergic disorders |
| 02/26/2004 | WO2004016578A2 Arylethanolamine beta2-adrenoreceptor agonist compounds |
| 02/26/2004 | WO2003097564A3 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof |
| 02/26/2004 | WO2002098424B1 Novel anti-infectives |
| 02/26/2004 | WO2002096869A3 Piperazine mono(dithio)carbamate ester compounds and analogs thereof |
| 02/26/2004 | US20040039207 Reacting a 1,3-cyclohexanedione with a homo-chiral phenylethylamine, reacting assymmetric vinlogous amide with alpha-beta-unsaturated ketone in presence of a silicon compound to form asymmetric diketone, then dihydropyridine |
| 02/26/2004 | US20040039034 Hydroxypropyl amides for the treatment of Alzheimer's disease |
| 02/26/2004 | US20040039017 Heterocyclic amines such as 2-(3-(4-Chloro-3-trifluoromethyl-benzylamino)prop-1-ylamino)-1H-quinolin-4 -one, used as G-protein coupled receptor inhibitors, for prophylaxis of cardiovascular disorders, schizophrenia or diabetes |
| 02/26/2004 | US20040038988 Novel crystalline forms of gatifloxacin |
| 02/26/2004 | US20040038977 Treating arthritis, pain and cancer |
| 02/26/2004 | US20040038969 Substituted aminopyrimidines and aminopyridazines; analgesics particularly for migraines, neuropathic pain and associated hyperalgesia and allodynia; antiinflammatory agents; treating asthma, gastrointestinal disorders, etc. |
| 02/26/2004 | US20040038957 Anti-malarial activity |
| 02/26/2004 | US20040038951 Organic compounds |
| 02/26/2004 | US20040038941 Compounds for the treatment of inflammatory disorders |
| 02/26/2004 | US20040038824 Agrochemical composition |
| 02/26/2004 | US20040037022 Aminoalcohol derivatives |
| 02/25/2004 | EP1391455A1 Process for preparation of a quinolinecarbaldehyde |
| 02/25/2004 | EP1391454A1 Substituted benzamide compounds with antihypertensive activity |
| 02/25/2004 | EP1390349A1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands |
| 02/25/2004 | EP1390340A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/25/2004 | EP1263756B1 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 02/25/2004 | EP1181269B1 Cell proliferation inhibitors |
| 02/25/2004 | EP1165064B1 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 02/25/2004 | EP1005446B1 N-aroylphenylalanine derivatives |
| 02/25/2004 | EP0984967B1 Naphthyridine derivatives and their analogues inhibiting cytomegalovirus |
| 02/25/2004 | CN1478085A ABCA-1 elevating compounds against coronary artery disease or atherosclerosis |